Progression of non-culprit coronary artery atherosclerosis after acute myocardial infarction in comparison with stable angina pectoris

Journal of Atherosclerosis and Thrombosis

Volumn 15, Issue 5, 2008, Pages 228-234

  Okayama, Satoshi ^a   Uemura, Shiro ^a   Nishida, Taku ^a   Morikawa, Yoshinobu ^a   Onoue, Kenji ^a   Takemoto, Yasuhiro ^a   Soeda, Tsunenari ^a   Somekawa, Satoshi ^a   Ishigami, Ken Ichi ^a   Takeda, Yukiji ^a   Horii, Manabu ^a   Kawata, Hiroyuki ^a   Takaoka, Minoru ^a   Nakajima, Tamio ^a   Saito, Yoshihiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Bare metal stent; Inflammation; Quantitative coronary angiography; Sirolimus eluting stent

Indexed keywords

EID: 56349140005     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.E539     Document Type: Article

References (35)

1. Gruntzig AR, Senning A, and Siegenthaler WE: Nonoperative dilatation of coronary-artery stenosis percutaneous transluminal coronary angioplasty. N Engl J Med, 1979, 301:61-68
2. Gruentzig AR, King SB 3rd, Schlumpf M, and Siegenthaler W: Long-term follow-up after percutaneous transluminal coronary angioplasty. The early zurich experience. N Engl J Med, 1987; 316:1127-1132
3. Simpfendorfer C, Belardi J, Bellamy G, Galan K, Franco I, and Hollman J: Frequency, management and follow-up of patients with acute coronary occlusion after percutaneous transluminal coronary angioplasty. Am J Cardiol, 1987; 59:267-269
4. Nobuyoshi M, Kimura T, Nosaka H, Mioka S, Ueno K, Yokoi H, Hamasaki N, Horiuchi P, and Ohishi H: Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients. J Am Coll Cardiol, 1988; 12:616-623
5. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, Detre K. Veltri L, Ricci D, Nobuyoshi M, Cleman M, Heuser R, Almond D, Teirsteiu PS, Fish RD, Colombo A, Brinker J, Moses J, Shaknovich A, Hirshfeld J, Bailey S, Ellis S, Ranke R, and Goldberg S: A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med, 1994; 331:496-501
6. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, Emanuelsson H, Marco J, Legrand V, Materne P, Belardi J, Sigwart U, Colombo A, Goy JJ, Heuvel PVD, Delcan J, and Morel MA: A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N Engl J Med, 1994; 331:489-495
7. Schömig A, Neumann FJ, Kastrati A, Schühlèn H, Blasini R, Hadamitzky M, Walter H, Zitzmann-Roth EM, Richardt G, Alt E, Schmitt C, and Ulm K: A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med, 1996; 334:1084-1089
8. Leon MB, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, Giambartolomei A, Diver DJ, Lasorda DM, Williams DO, Pocock SJ, and Kuntz RE: A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. Stent Anticoagulation Restenosis Study Investigators. N Engl J Med, 1998; 339:1665-1671
9. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, and Kuntz RE: SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med, 2003; 349:1315-1323
10. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnàr F, and Falotico R: PAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Fngl J Med, 2002; 346:1773-1780
11. McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T, Suddath WO, Weissman NJ, Torguson R, Kent KM, Pichard AD, Satler LF, Waksman R, and Serruys PW: Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet, 2004; 364:1519-1521
12. Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, and Leon MB: Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med, 2007; 356:1059-1060
13. Hon-Kan Yip, Pei-wen Wang, Li-Teh Chang, Ali A, Youssef, Jiunn-Jye Sheu, Fan-Yen Lee, and Chiung-Jen Wu: Cytotoxic T lymphocyte antigen 4 gene polymorphism associated with T-segment elevation acute myocardial infarction. Circ J, 2007; 71:1213-1218
14. Wojakowski W, Maslankiewicz K, Ochala A, Wyderka R, Zuk-Popiolek J, Flak Z, Mroz I, and Tendera M: The pro- and anti-inflammatory markers in patients with acute myocardial infarction and chronic stable angina. Int J Mol Med, 2004; 14:317-322
15. Ashida K, Miyazaki K, Takayama E, Tsujimoto H, Ayaori M, Yakushiji T, Iwamoto N, Yonemura A, Isoda K, Mochizuki H, Hiraide H, Kusuhara M, and Ohsuzu F: Characterization of the expression of TLR2 (toll-like receptor 2) and TLR4 on circulating monocytes in coronary artery disease. J Atheroscler Thromb, 2005; 12:53-60
16. Zhou RH, Shi Q, Gao HQ, and Shen BJ: Changes in serum interleukin-8 and interleukin-12 levels in patients with ischemic heart disease in a Chinese population. J Atheroscler Thromb, 2001; 8:30-32
17. Kawamura A, Miura S, Murayama T, Iwata A, Nishikawa H, Matsuo Y, Tsuchiya Y, Matsuo K, Tsuji E, and Saku K: Changes in the expression of leukocyte adhesion molecules throughout the acute phase of myocardial infarction. J Atheroscler Thromb, 2004; 11:29-34
18. Ehara S, Kobayashi Y, Yoshiyama M, Ueda M, and Yoshikawa J: Coronary artery calcification revisited. J Atheroscler Thromb, 2006; 13:31-37
19. Chen L, Chester MR, Crook R, and Kaski JC: Differential progression of complex culprit stenoses in patients with stable and unstable angina pectoris. J Am Coll Cardiol, 1996; 28:597-603
20. Frangogiannis NG, Smith CW, and Entman ML: The inflammatory response in myocardial infarction. Cardiovasc Res, 2002; 53:31-47
21. Aoki M, Morishita R, Taniyama Y, Kaneda Y, and Ogihara T: Therapeutic angiogenesis induced by hepatocyte growth factor: potential gene therapy for ischemic diseases. J Atheroscler Thromb, 2000; 7:71-76
22. Takaoka M, Uemura S, Kawata H, Imagawa K, Takeda Y, Nkatani K, Naya N, Horii M, Yamano S, Miyamoto Y, Yoshimasa Y, and Saito T: Inflammatory response to acute myocardial infarction augments neointimal hyperplasia after vascular injury in a remote artery. Arterioscler Thromb Vasc Biol, 2006; 26:2083-2089
23. Teramoto T, Sasaki J, Ueshima H, Egusa G, Kinoshita M, Shimamoto K, Daida H, Biro S, Hirobe K, Funahashi T, Yokote K, and Yokode M; Japan Atherosclerosis Society (JAS). Committee for Epidemiology and clinical Management of Atherosclerosis: Diagnostic criteria for dyslipidemia. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese. J Atheroscler Thromb, 2007; 14:155-158
24. Kinoshita M, Ishikawa K, Inoue H, Sakakibara H, Kanmatsuse K, Saito Y, Nonogi H, Hiramori K, Suzuki T, Nakamura Y, Katagiri T, Shirato K, Fujita M, Maruyama Y, and Miura M: Guidelines for secondary prevention of myocardial infarction. Jpn Circ J, 2000, 65 Supple. IV:863-867
25. Saito Y, Shirai K, Sasaki N, Shinomiya M, and Yoshida S: Prognosis of hypercholesterolemic patients taking pravastatin for five years: The Chiba lipid intervention program (CLIP) study. J Artheroscler Thromb, 2002; 9:99-108
26. Koizumi J, Shimizu M, Miyamoto S, Origasa H, and Mabuchi H: Effect of pravastatin-induced LDL-cholesterol reduction on coronary heart-disease and cerebrovascular disease in Japanese: Hokuriku lipid coronary heart disease study-pravastatin atherosclerosis trial (Holicos-PAT). J Atheroscler Thromb, 2002; 9:251-259
27. Parisi AF, Moynihan PF, Feldman CL, and Folland ED: Approaches to determination of left ventricular volume and ejection fraction by real-time two-dimensional echocardiography. Clin Cardiol, 1979;2:257-263
28. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, Han KH, Kang DH, Song JK, Kim JJ, Park SW, and Park SJ: Comparison of coronary plaque rupture between stable angina and acute myocardial infarction: A three-vessel intravascular ultrasound study in 235 patients. Circulation, 2004; 110:928-933
29. Hasegawa T, Negishi T, and Deguchi M: WBC count, atherosclerosis and coronary risk factors. J Atheroscler Thromb, 2002; 9:219-223
30. Azar RR, McKay RG, Kiernan FJ, Seecharran B, Feng YJ, Fram DB, Wu AH, and Waters DD: Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol, 1997; 80:1476-1478
31. Gaspardone A, Crea F, Versaci F, Tomai F, Pellegrino A, Chiariello L, and Gioffré PA: Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am J Cardiol, 1998; 82:515-518
32. Angioi M, Abdelmouttaleb I, Rodriguez RM, Aimone-Gastin I, Adjalla C, Guéant JL, and Danchin N: Increased C-reactive protein levels in patients with in-stent restenosis and its implications, Am J Cardiol, 2001; 87:1189-1193
33. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, Meier B, and Hess OM: Sirolimus-eluring stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol, 2005; 46:231-236
34. Inoue T, Sata M, Hikichi Y, Sohma R, Fukuda D, Uchida T, Shimizu M, Komoda H, and Node K: Mobilization of CD34-positive bone marrow-derived cells after coronary stent implantation. Impact on restenosis. Circulation, 2007; 115:553-561
35. Otsuka Y, Nakamura M, Yasuda S, Kozuma K, Hara H, Morii I, Kawamura A, Sase K, and Miyazaki S: Comparison of pharmacokinetics of the sirolimus-eluting stent in Japanese patients with those in American patients. J Cardiovasc Pharmacol, 2005, 46:468-473